Treatment characteristics

The following data visualisation shows:

  • Closed episodes where pharmacotherapy was the main treatment by principal drug of concern, 2018–19 (AODTS NMDS 2018–19).
  • Closed episodes where pharmacotherapy was the main treatment by source of referral, 2018–19 (AODTS NMDS 2018–19)
  • Closed episodes where pharmacotherapy was the main treatment by delivery setting 2018–19 (AODTS NMDS 2018–19).
  • Clients receiving pharmacotherapy treatment by opioid drug of dependence, 2019 (NOPSAD collection 2019).
  • Clients receiving pharmacotherapy treatment by prescriber type, 2019 (NOPSAD collection 2019).
  • Clients receiving pharmacotherapy treatment by dosing point site, 2019 (NOPSAD collection 2019).

The AODTS NMDS dashboard shows that heroin was the principal drug of concern in 36% of closed treatment episodes where pharmacotherapy was the main treatment type. Where pharmacotherapy was the main treatment type in 2018–19, self/family was the most common (58% of closed treatment episodes) source of referral and non-residential treatment facilities was the most common (96%) treatment delivery setting among those receiving treatment for their own drug use. The NOPSAD collection dashboard shows that heroin was the most common (37% of clients) opioid drug of dependence in 2019. On a snapshot day in June 2019, 65% of clients received pharmacotherapy treatment from a private prescriber and 72% were dosed at a pharmacy.  

Visualisation not available for printing